Correlation Between Evogene and OncoCyte Corp
Can any of the company-specific risk be diversified away by investing in both Evogene and OncoCyte Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evogene and OncoCyte Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evogene and OncoCyte Corp, you can compare the effects of market volatilities on Evogene and OncoCyte Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evogene with a short position of OncoCyte Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evogene and OncoCyte Corp.
Diversification Opportunities for Evogene and OncoCyte Corp
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Evogene and OncoCyte is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Evogene and OncoCyte Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OncoCyte Corp and Evogene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evogene are associated (or correlated) with OncoCyte Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OncoCyte Corp has no effect on the direction of Evogene i.e., Evogene and OncoCyte Corp go up and down completely randomly.
Pair Corralation between Evogene and OncoCyte Corp
Given the investment horizon of 90 days Evogene is expected to under-perform the OncoCyte Corp. In addition to that, Evogene is 1.26 times more volatile than OncoCyte Corp. It trades about -0.1 of its total potential returns per unit of risk. OncoCyte Corp is currently generating about 0.0 per unit of volatility. If you would invest 301.00 in OncoCyte Corp on September 4, 2024 and sell it today you would lose (56.00) from holding OncoCyte Corp or give up 18.6% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Evogene vs. OncoCyte Corp
Performance |
| Timeline |
| Evogene |
| OncoCyte Corp |
Evogene and OncoCyte Corp Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Evogene and OncoCyte Corp
The main advantage of trading using opposite Evogene and OncoCyte Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evogene position performs unexpectedly, OncoCyte Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OncoCyte Corp will offset losses from the drop in OncoCyte Corp's long position.| Evogene vs. Candel Therapeutics | Evogene vs. Anebulo Pharmaceuticals | Evogene vs. Cingulate Warrants | Evogene vs. Unicycive Therapeutics |
| OncoCyte Corp vs. Candel Therapeutics | OncoCyte Corp vs. Anebulo Pharmaceuticals | OncoCyte Corp vs. Cingulate Warrants | OncoCyte Corp vs. Unicycive Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |